Blog
RSS FeedPosted by Michael Wonder on 18 Aug 2021
Joint statement from HHS public health and medical experts on COVID-19 booster shots
18 August 2021 - Today, public health and medical experts from the U.S. Department of Health and Human Services released the ...
Posted by Michael Wonder on 16 Aug 2021
Pfizer and BioNTech announce submission of initial data to U.S. FDA to support booster dose of COVID-19 vaccine
16 August 2021 - Phase 1 safety and immunogenicity data in individuals who received a third dose of the Pfizer-BioNTech vaccine ...
Posted by Michael Wonder on 16 Aug 2021
U.S. FDA approves Ticovac, Pfizer's tick borne encephalitis vaccine
13 August 2021 - Ticovac may help reduce the risk of tick-borne encephalitis for people traveling to endemic areas, potentially including ...
Posted by Michael Wonder on 15 Aug 2021
Coronavirus (COVID-19) update: FDA authorises additional vaccine dose for certain immunocompromised individuals
12 August 2021 - Other fully vaccinated individuals do not need an additional vaccine dose right now. ...
Posted by Michael Wonder on 12 Aug 2021
FDA to authorise third vaccine dose for people with weak immune systems
11 August 2021 - The decision to expand the emergency use of both the Pfizer-BioNTech and Moderna vaccines is meant to ...
Posted by Michael Wonder on 11 Aug 2021
Pressure builds for full FDA approval of vaccines
11 August 2021 - Pressure is building for the FDA to fully approve the COVID-19 vaccine, a step that could ...
Posted by Michael Wonder on 06 Aug 2021
Novavax delays Covid vaccine emergency authorisation submission to FDA until fourth quarter
5 August 2021 - The company says it is still on track to produce 100 million doses per month by the ...
Posted by Michael Wonder on 04 Aug 2021
FDA reportedly hopes to fully approve Pfizer’s Covid vaccine by Labor Day
3 August 2021 - Federal regulators are aiming to grant full approval to Pfizer’s coronavirus vaccine by early September, the New ...
Posted by Michael Wonder on 03 Aug 2021
Moderna receives FDA fast track designation for respiratory syncytial virus vaccine (mRNA-1345)
3 August 2021 - Moderna today announced that the U.S. FDA has granted fast track designation for mRNA-1345, its investigational ...
Posted by Michael Wonder on 03 Aug 2021
The FDA finally gets moving on Pfizer
2 August 2021 - The agency will now ‘sprint’ to grant full vaccine approval. ...
Posted by Michael Wonder on 03 Aug 2021
GSK files for licensure of MMR vaccine in the US
2 August 2021 - GSK seeks US approval of Priorix vaccine licensed in more than 100 countries. ...
Posted by Michael Wonder on 01 Aug 2021
FDA under pressure to grant full approval to COVID-19 vaccines
1 August 2021 - Some schools, hospitals and employers are hesitant to mandate vaccines while shots are still only authorized for ...
Posted by Michael Wonder on 29 Jul 2021
FDA says it's working as fast as possible to fully approve vaccines, as urgency rises amid COVID-19 surge
29 July 2021 - The US FDA insists it is working as quickly as possible to review applications for full ...
Posted by Michael Wonder on 28 Jul 2021
FDA says its 'working as quickly as possible' to review for full approval of vaccines
27 July 2021 - Some say full approval could sway hesitant Americans to get the vaccine. ...
Posted by Michael Wonder on 26 Jul 2021
FDA asks Pfizer, Moderna to test their vaccines in more children to help rule out safety issues
26 July 2021 - Federal regulators have requested that vaccine companies expand their trials to test coronavirus shots in several ...